FABPULOUS
FABPulous is an innovative healthcare company which develops and markets solutions for diagnostics in primary care and emergency medicine. FABPulous is a company based in The Netherlands. It was spun out of Maastricht University at the end of 2008. In December 2009 FABPulous closed a first equity financing round co-led by Thuja Capital, Health Innovations, Limburg Ventures and NV Industriebank LIOF. The company has developed a technology that allows a simple, robust and ultra-rapid diluted pla... sma preparation from a drop of blood. This offers great advantages in the point-of-care (POC) and home testing setting, over current technology. It concerns a disposable plasma preparation device that can be integrated with many IVD detection platforms, such lateral flow devices. The first product application under development by FABPulous is a rapid test for the cardiac biomarker heart-type fatty acid binding protein (H-FABP), to aid in the first-line diagnosis of acute myocardial infarction.
FABPULOUS
Industry:
Biotechnology Health Care Medical
Founded:
2000-01-01
Address:
Maastricht, Limburg, The Netherlands
Country:
The Netherlands
Website Url:
http://www.fabpulous.com
Total Employee:
1+
Status:
Active
Contact:
+31 (0)6 30892786
Email Addresses:
[email protected]
Total Funding:
3.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Content Delivery Network Amazon YouTube OpenResty AdBlock Acceptable Ads Shockwave Flash Embed Bodis DNS
Similar Organizations
BodyTel GmbH
BodyTel GmbH is a telemedicine company, which has developed a comprehensive monitoring and management system for chronic illnesses.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Kuros Biosciences
Kuros Biosurgery develops biomaterials and bioactive biomaterial combination products for indications in trauma, wound and spine.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Sinocelltech
Sinocelltech is a biotech company that develops and manufactures recombinant proteins, monoclonal antibodies, and vaccines.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Current Employees Featured
Founder
Investors List
Health Innovation Fund
Health Innovation Fund investment in Venture Round - FABPulous
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - FABPulous
Limburg Ventures
Limburg Ventures investment in Series B - FABPulous
Health Innovation Fund
Health Innovation Fund investment in Series B - FABPulous
Thuja Capital
Thuja Capital investment in Series B - FABPulous
Limburg Ventures
Limburg Ventures investment in Series A - FABPulous
Medavinci
Medavinci investment in Series A - FABPulous
Thuja Capital
Thuja Capital investment in Series A - FABPulous
NV Industriebank LIOF
NV Industriebank LIOF investment in Series A - FABPulous
Health Innovation Fund
Health Innovation Fund investment in Series A - FABPulous
Official Site Inspections
http://www.fabpulous.com
- Host name: lb-182-243.above.com
- IP address: 103.224.182.243
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney
More informations about "FABPulous"
FABPulous - Crunchbase Company Profile & Funding
FABPulous is an innovative healthcare company which develops and markets solutions for diagnostics in primary care and emergency medicine. FABPulous …See details»
FABPulous Company Profile 2025: Valuation, Funding & Investors
What industry is FABPulous in? FABPulous’s primary industry is Diagnostic Equipment. Is FABPulous a private or public company? FABPulous is a Private company. What is …See details»
FABPulous - Funding, Financials, Valuation & Investors - Crunchbase
FABPulous is an innovative healthcare company which develops and markets solutions for diagnostics in primary care and emergency medicine. Search Crunchbase. ... How much …See details»
FABPulous BV - Business Profile - FABPulous | PRLog
View FABPulous BV's business profile on PRLog, with profiles from 390,000 organizations. FABPulous develops and markets pioneering Point of Care (PoC) solutions for better …See details»
FABPulous BV - Company Profile and News - Bloomberg Markets
Company profile page for FABPulous BV including stock price, company news, executives, board members, and contact informationSee details»
FABPulous - Overview, News & Similar companies | ZoomInfo.com
Who is FABPulous. FABPulous is a venture capital-backed company that was spun out of Maastricht University at the end of 2008. In December 2009 FABPulous closed a fi rst equity …See details»
FABPulous - Contacts, Employees, Board Members, Advisors
FABPulous is an innovative healthcare company which develops and markets solutions for diagnostics in primary care and emergency medicine. Search Crunchbase. Start Free Trial . …See details»
FABPulous - VentureRadar
FABPulous develops a disposable device which allows for rapid semi-quantitative diagnostic testing in blood or plasma. The first application is for diagnosis of acute myocardial infarction, …See details»
www.fabpulous.com
Www.fabpulous.comSee details»
FABPulous BV closes Series B Funding; Begins …
Feb 4, 2015 FABPulous is a venture capital-backed company that was spun out of Maastricht University at the end of 2008. In December 2009 FABPulous closed a first equity financing round co-led by Thuja Capital, Health Innovations, …See details»
Validation of a point-of-care H-FABP test for a rapid exclusion of ...
Aug 8, 2022 FABPulous (SME) is a medical device company spun out of Maastricht University in 2008. The core of the company is its innovative proprietary technology that allows a simple, …See details»
Fabpulous - Dealmaker
FABPulous B.V. founded in 2008, develops and produces ultra-rapid point-of-care diagnostic tests that are used in the first line medical care for the determination of acute tissue injuries. The …See details»
FABPulous BV Announces evolved Executive Management Team
Following successful completion of the €2.2m Series B funding round, FABPulous BV reorganises roles within an enlarged management team to meet the challenges of evolution from R&D start …See details»
FABPulous - Crunchbase
FABPulous is an innovative healthcare company which develops and markets solutions for diagnostics in primary care and emergency medicine. Search Crunchbase. Start Free Trial . …See details»
FABPULOUS LIMITED overview - Find and update company …
FABPULOUS LIMITED. Company number 09021561. Follow this company Company Overview for FABPULOUS LIMITED (09021561) Filing history for FABPULOUS LIMITED (09021561) …See details»
FABPulous - Brightlands Venture Partners
FABPulous develops a disposable device which allows for rapid semi-quantitative diagnostic testing in blood or plasma. The first application is for diagnosis of acute myocardial infarction, …See details»
FABPulous BV - Latest News - PRLog
View FABPulous BV's latest news on PRLog, with news from 390,000 organizations. FABPulous BV has 3 news items. FABPulous develops and markets pioneering Point of Care (PoC) …See details»
FABPulous - Products, Competitors, Financials, Employees, …
FABPulous is a renowned pump industry group company specializing in the research, development, design, production, and sales of pumps, water supply equipment, electric …See details»
FABPulous - Tech Stack, Apps, Patents & Trademarks - Crunchbase
FABPulous is an innovative healthcare company which develops and markets solutions for diagnostics in primary care and emergency medicine. Search Crunchbase. Start Free Trial . …See details»
FABPulous wins €1.6m EU grant for clinical trials, 5 minuteheart …
FABPulous wins €1.6m EU grant for clinical trials of 5 minuteheart attack test. July 20th 2015, Maastricht (Netherlands) – The European Union awarded FABPulous BV a €1.6 million Phase …See details»